Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 11—November 2007
Research

Human Salmonella and Concurrent Decreased Susceptibility to Quinolones and Extended-Spectrum Cephalosporins

Jean M. Whichard*Comments to Author , Kathryn Gay*1, Jennifer E. Stevenson*2, Kevin J. Joyce*, Kara L. Cooper*, Michael Omondi*, Felicita Medalla*, George A. Jacoby†, and Timothy J. Barrett*
Author affiliations: *Centers for Disease Control and Prevention, Atlanta, Georgia, USA; †Lahey Clinic, Burlington, Massachusetts, USA;

Main Article

Table 3

Susceptibility results for NARMS non-Typhi Salmonella isolates with decreased susceptibility to quinolones and extended-spectrum cephalosporins, United States, 1996–2004*

Isolate Resistance
NAL CIP XNL CRO TAZ TAZ/ CLAV FOT FOT/
CLAV Other†
AM18280 >32 0.25 >8 16 32 16/4 16 8/4 AMP, AMC, CHL, FOX, KAN, STR, SUL, SXT, TET
AM09124 >32 0.5 2 <0.25 0.5 0.25/4 0.25 0.12/4 ND
AM15266 >32 0.5 2 <0.25 0.5 0.25/4 0.25 0.12/4 (CHL)
AM12389 >32 0.5 2 <0.25 0.25 0.25/4 0.1 0.12/4 (CHL), SUL, SXT, TET
AM15010 16 0.25 8 8 64 0.5/4 4 0.25/4 AMP, (CHL), SUL, SXT
AM03005 16 0.25 2 0.5 0.25 0.12/4 0.12 ≤0.06/4 AMP, AMC, CHL, FOX, (GEN), KAN, STR, SUL, SXT
AM15201 >32 0.12 >8 8 16 16/4 16 8/4 AMP, AMC, CHL, FOX, STR, SUL, TET
AM21465 >32 0.12 >8 16 16 16/4 8 8/4 AMP, AMC, CHL, FOX, STR, SUL, TET
AM20428 >32 0.5 2 <0.25 0.5 0.5/4 0.5 0.12/4 (CHL), (FOX)
AM06960 >32 >4 8 8 0.5 0.25/4 1 0.12/4 AMP, AMC, (CHL), GEN, KAN, STR, SUL, SXT
AM08081 >32 >4 4 0.5 0.5 0.25/4 1 0.12/4 AMP, AMC, CHL, FOX, (GEN), KAN, STR, SUL, SXT
AM08208 >32 >4 2 <0.25 0.5 0.25/4 0.5 0.25/4 AMP, (AMC) CHL, GEN, KAN, STR, SUL, SXT, TET
AM09864 >32 >4 8 8 64 0.25/4 8 0.25/4 AMP, (CHL), (FOX), GEN, KAN
AM11007 >32 >4 4 0.5 1 0.5/4 1 0.5/4 AMP, AMC, CHL, (FOX), KAN, SUL
AM14058 >32 >4 >8 >64 64 64/4 128 >64/4 (AMI), AMP, AMC, CHL, FOX, KAN, SUL
AM16094 >32 >4 4 <0.25 0.5 0.25/4 1 0.25/4 AMP, (AMC), CHL, (FOX), (GEN), KAN, SUL, SXT
AM18622 >32 >4 8 1 2 0.5/4 4 0.5/4 AMP, AMC, CHL, KAN, STR, SUL, SXT
AM19422 >32 >4 4 <0.25 0.5 0.5/4 2 0.25/4 AMP, AMC, (GEN), KAN, STR, SUL, SXT
AM20227 >32 >4 2 <0.25 1 2/4 1 0.5/4 AMP, AMC, (CHL), (FOX), GEN, KAN, STR, SUL, SXT
AM20256 >32 >4 4 <0.25 0.5 0.5/4 1 0.25/4 AMP, (AMC), (CHL), (GEN), KAN, SUL, SXT
AM02544 256 0.25 >16 64 128 0.5/4 32 0.12/4 AMP, (AMC), KAN, STR, SUL, TET
AM08739 >32 0.25 >8 32 16 16/4 16 8/4 AMP, AMC, CHL, FOX, GEN, KAN, STR, SUL, TET
AM11682 >32 0.25 >8 16 16 8/4 16 8/4 AMP, AMC, FOX
AM14364 >32 0.25 >8 32 32 16/4 32 16/4 AMP, AMC, CHL, FOX, GEN, KAN, STR, SUL, TET
AM14807 >32 0.25 >8 16 32 16/4 16 32/4 AMP, AMC, CHL, FOX, STR, SUL, TET
AM20205 >32 0.25 2 <0.25 0.5 0.5/4 0.25 0.25/4 AMP, KAN, STR, SUL, TET
AM19537 >32 0.12 >8 16 16 16/4 8 8/4 AMP, AMC, CHL, FOX, (GEN), (KAN), STR, SUL TET

*NARMS, National Antimicrobial Resistance Monitoring System; NAL, nalidixic acid; CIP, ciprofloxacin; XNL, ceftiofur; CRO, ceftriaxone; TAZ, ceftazidime; TAZ/CLAV, ceftazidime/clavulanate; FOT, cefotaxime, FOT/CLAV, cefotaxime/clavulanate; AMP, ampicillin; AMC, amoxicillin/clavulanate; CHL, chloramphenicol; FOX, cefoxitin; KAN, kanamycin; STR, streptomycin; SUL, sulfamethoxazole or sulfisoxazole; SXT, trimethoprim/sulfamethoxazole; TET, tetracycline; AMI, amikacin; GEN, gentamicin.
†Drugs in parentheses had intermediate results.

Main Article

1Current affiliation: Banfield, The Pet Hospital, Philadelphia, Pennsylvania, USA

2Current affiliation: Washington State University, Pullman, Washington, USA

Page created: July 05, 2010
Page updated: July 05, 2010
Page reviewed: July 05, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external